Comparison of non-invasive sampling methods for detection of HPV in rural African women
Open Access
- 1 June 2005
- journal article
- research article
- Published by BMJ in Sexually Transmitted Infections
- Vol. 81 (3) , 239-241
- https://doi.org/10.1136/sti.2004.010413
Abstract
Background: The prevalence of cervical cancer is extremely high in low income countries, primarily because of a lack of cytological screening. The link between human papillomavirus (HPV) and cervical cancer has long been recognised, and it has been suggested that isolated HPV testing in women who do not participate in existing screening programmes may be used to identify women at higher risk of developing cervical cancer. This community based study compares two self administered techniques for detecting HPV (tampons and self administered swabs) with a clinician directed technique, the cervical cytobrush. Methods: 377 rural women were interviewed and of these 210 women had full gynaecological examination, and accepted all three sampling methods for HPV. HPV typing of DNA extracts was performed using polymerase chain reaction and enzyme linked immunosorbent assay techniques. Results: Using the cervical cytobrush as the gold standard, self administered swabs (SAS) showed a sensitivity of 63.9%, and tampons showed a sensitivity of 72.4%. The acceptability of these two tests was 97.1% and 84.6% respectively. When combining acceptability with sensitivity, the SAS detected 61.9% and the tampons detected 60.9% of the true positives. Conclusion: In a setting where women are at a considerable risk of developing cervical cancer, with no access to a formal screening programme, self directed HPV testing could be a useful screening tool in identifying those women at increased risk who may require further investigation.Keywords
This publication has 11 references indexed in Scilit:
- Management of women who test positive for high-risk types of human papillomavirus: the HART studyThe Lancet, 2003
- Comparison of HPV-based assays with Papanicolaou smears for cervical cancer screening in Morelos State, Mexico.Cancer Causes & Control, 2003
- Randomized clinical trial of PCR–determined human papillomavirus detection methods: Self-sampling versus clinician-directed–Biologic concordance and women's preferencesAmerican Journal of Obstetrics and Gynecology, 2002
- The burden of reproductive-organ disease in rural women in The Gambia, West AfricaThe Lancet, 2001
- Human papillomavirus is a necessary cause of invasive cervical cancer worldwideThe Journal of Pathology, 1999
- Relation of human papilloma virus status to cervical lesions and consequences for cervical-cancer screening: a prospective studyThe Lancet, 1999
- Estimates of the worldwide incidence of 25 major cancers in 1990International Journal of Cancer, 1999
- A general primer GP5+/GP6(+)-mediated PCR-enzyme immunoassay method for rapid detection of 14 high-risk and 6 low-risk human papillomavirus genotypes in cervical scrapings.1997
- Human papillomavirus testing in primary cervical screeningThe Lancet, 1995
- Condylomata acuminata and human genital cancer.1976